BOERINGER INGLHEIM PORTUGAL secures contract for Idarucizumab 25 G/50 Ml Sol Inj Fr 50 Ml Iv

Portugal, Aug. 3 -- Portugal based BOERINGER INGLHEIM PORTUGAL has secured contract from Unidade Local De Saude De Almada-Seixal, E.P.E. for Idarucizumab 25 G/50 Ml Sol Inj Fr 50 Ml Iv . The value of the contract is worth 4016 EUR .

Published by HT Digital Content Services with permission from Pivotal Sources....